In some embodiments is an enhanced viscosity formulation, comprising from about 0.1 mM and about 100 mM of an active agent, a pharmaceutically acceptable viscosity enhancer or viscosity modulating agent, and water for injection, the concentration of the viscosity enhancer or viscosity modulating agent in the water being sufficient to provide an enhanced viscosity formulation with a final viscosity from about 100 to about 100,000 cP
This systems-level approach is increasingly common in modern regenerative biology research
NAD+ has extensive biochemical
not approved by the FDA, EMA or other agencies
14 weeks Reduced tingling & burning for some patients 23 months Better sensation, improved balance, reduced pain 6 months+ Nerve repair and long-term function improvement Severe or long-standing neuropathy may require ongoing treatment
"And there's minimal evidence on the side effects or consequences of long-term or frequent dosing." "It's great to see that we're on this route of health, wellness and recovery, but we need more evidence and research before we can make a true recommendation," he said
